Home 
Today's Top Picks 
Top Performers 
Watchlist 
My Robo Portfolios 
ETF Zone 
Help & Tutorial - Chart
- Upturn Summary
- Highlights
- Valuation
Upturn AI SWOT - About
AFYA 
Afya Ltd (AFYA)
- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- Pass (Skip investing)
Stock price based on last close (see disclosures)
- ALL
- 1Y
- 1M
- 1W
Upturn Advisory Summary
11/05/2025: AFYA (1-star) is currently NOT-A-BUY. Pass it for now.
Upturn Star Rating
Not Recommended Performance
These Stocks/ETFs, based on Upturn Advisory, consistently fall short of market performance, signaling caution before investing.
Number of Analysts
9 Analysts rated it
Limited analyst coverage, niche firm, research info may be scarce.
1 Year Target Price $19.26
1 Year Target Price $19.26
| 1 | Strong Buy |
| 2 | Buy |
| 2 | Hold |
| 1 | Sell |
| 3 | Strong Sell |
Analysis of Past Performance
Type Stock | Historic Profit -44.72% | Avg. Invested days 23 | Today’s Advisory PASS |
Upturn Star Rating | Upturn Advisory Performance  2.0 | Stock Returns Performance  1.0 |
| Profits based on simulation | Last Close 11/05/2025 |
Key Highlights
Company Size Small-Cap Stock | Market Capitalization 1.30B USD | Price to earnings Ratio 10.16 | 1Y Target Price 19.26 |
Price to earnings Ratio 10.16 | 1Y Target Price 19.26 | ||
Volume (30-day avg) 9 | Beta 0.53 | 52 Weeks Range 13.47 - 19.90 | Updated Date 11/5/2025 |
52 Weeks Range 13.47 - 19.90 | Updated Date 11/5/2025 | ||
Dividends yield (FY) 1.64% | Basic EPS (TTM) 1.41 |
Earnings Date
Report Date 2025-11-13 | When - | Estimate 1.76 | Actual - |
Profitability
Profit Margin 19.58% | Operating Margin (TTM) 31.02% |
Management Effectiveness
Return on Assets (TTM) 8.42% | Return on Equity (TTM) 16.45% |
Valuation
Trailing PE 10.16 | Forward PE 7.86 | Enterprise Value 1792679527 | Price to Sales(TTM) 0.37 |
Enterprise Value 1792679527 | Price to Sales(TTM) 0.37 | ||
Enterprise Value to Revenue 2.7 | Enterprise Value to EBITDA 6.16 | Shares Outstanding 47008252 | Shares Floating 8007715 |
Shares Outstanding 47008252 | Shares Floating 8007715 | ||
Percent Insiders 68.11 | Percent Institutions 19.26 |
Upturn AI SWOT
Afya Ltd
Company Overview
History and Background
Afya Ltd. was founded in 2019, after a consolidation of several medical education institutions in Brazil. It rapidly expanded through acquisitions to become a leading player in the medical education sector.
Core Business Areas
- Medical Education: Offers undergraduate and graduate medical education programs, including medicine, dentistry, and nursing.
- Continuing Medical Education (CME) and Digital Services: Provides CME courses, digital solutions for medical professionals, and other services related to healthcare training.
Leadership and Structure
Afya Ltd. has a structured leadership team headed by a CEO and several vice presidents overseeing different operational areas. The company's board of directors provides strategic oversight.
Top Products and Market Share
Key Offerings
- Undergraduate Medical Education: Afya is the largest medical school group in Brazil with thousands of medical seats offered each year. The competitors include Estacio, UNIP, and Laureate Education.
- CME and Digital Services: Carries a portfolio of digital products such as iClinic (EHR system) and PEBMED(medical information apps). Competitors includes Medscape, Figure 1, and UpToDate.
Market Dynamics
Industry Overview
The medical education industry in Brazil is growing due to increasing demand for healthcare professionals. This growth is driven by an aging population and the expansion of healthcare access.
Positioning
Afya Ltd. is positioned as a leading player in the Brazilian medical education market, with a strong focus on quality and innovation.
Total Addressable Market (TAM)
The TAM for medical education and related services in Brazil is estimated to be significant and growing, driven by the need for qualified healthcare professionals. Afya is well-positioned to capture a substantial portion of this market.
Upturn SWOT Analysis
Strengths
- Leading market position in Brazil
- Strong brand recognition
- Extensive network of medical schools
- Innovative digital solutions
Weaknesses
- Concentration in a single geographic market (Brazil)
- Regulatory risks in the education sector
- Potential for increased competition
- Exposure to currency fluctuations
Opportunities
- Further expansion in Brazil and other Latin American countries
- Development of new digital products and services
- Partnerships with healthcare providers
- Government support for medical education
Threats
- Changes in government regulations
- Economic downturns in Brazil
- Increased competition from other educational institutions
- Technological disruption
Competitors and Market Share
Key Competitors
- YDUQ3.SA
- COGN3.SA
- CRDE3.SA
Competitive Landscape
Afya has a competitive advantage with a specialization in Medical education, where as the other competitors have education in general. This specialisation provides Afya with higher revenue per student due to the high demand for medical seats and specialisation.
Major Acquisitions
iClinic
- Year: 2019
- Acquisition Price (USD millions): 45
- Strategic Rationale: Acquisition of iClinic enabled Afya to expand its digital ecosystem by adding EHR (Electronic Health Record) and practice management solutions catering to physicians.
Growth Trajectory and Initiatives
Historical Growth: Afya has demonstrated significant historical growth through acquisitions and organic expansion of its educational programs.
Future Projections: Analyst estimates suggest continued growth for Afya, driven by increasing demand for medical education and the company's strategic initiatives.
Recent Initiatives: Afya has recently focused on expanding its digital platform, acquiring new educational institutions, and enhancing its curriculum.
Summary
Afya Ltd. is a leading medical education provider in Brazil, demonstrating strong growth and a strategic focus on digital solutions. Its strong market position and focus on high demand education areas allow it to demand premium pricing. The company faces potential headwinds from economic factors and competition. Afya must be wary of regulatory changes in the education sector.
Similar Stocks
Sources and Disclaimers
Data Sources:
- Company filings
- Analyst reports
- Industry publications
Disclaimers:
The information provided is for informational purposes only and should not be considered financial advice. Investment decisions should be made based on individual research and consultation with a financial advisor.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About Afya Ltd
Exchange NASDAQ | Headquaters Nova Lima, MG, Brazil | ||
IPO Launch date 2019-07-19 | CEO - | ||
Sector Consumer Defensive | Industry Education & Training Services | Full time employees - | Website https://www.afya.com.br |
Full time employees - | Website https://www.afya.com.br | ||
Afya Limited operates as a medical education group in Brazil. The company operates in three segments: Undergrad, Continuing Education, and Digital Services. It offers educational products and services, including medical schools, medical residency preparatory courses, graduate courses, and other programs to lifelong medical learners enrolled across its distribution network, as well as to third-party medical schools. The company also provides digital health services, such as subscription-based mobile app and website portal that focuses on assisting health professionals and students with clinical decision-making through tools, such as medical calculators, charts, and updated content, as well as prescriptions, clinical scores, medical procedures and laboratory exams, and others. In addition, it offers printed and digital content, as well as an online medical education platform and practical medical training services. Further, the company offers iClinic, a practice management software; educational health and medical imaging solutions through an interactive platform; Cliquefarma, a free-to-use website that tracks prescription drugs, cosmetics, and personal hygiene product prices; Shosp, a clinical management software; RX PRO, a solution that connects physicians with the pharmaceutical industry; and Glic, a free diabetes care and management app solution for physicians and patients. Afya Limited was founded in 1999 and is headquartered in Nova Lima, Brazil.
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.